| Chad Michael Feldman, MD | |
|
141 W 22nd St Ste 109, Anderson, IN 46016-4315 | |
| (765) 646-8538 | |
| Not Available |
| Full Name | Chad Michael Feldman |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 21 Years |
| Location | 141 W 22nd St Ste 109, Anderson, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134333289 | NPI | - | NPPES |
| 201024520 | Medicaid | IN | |
| 000000714410 | Other | IN | ANTHEM BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 01069648A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ascension St Vincent Anderson | Anderson, IN | Hospital |
| Community Hospital Of Anderson And Madison County | Anderson, IN | Hospital |
| Ascension St Vincent Kokomo | Kokomo, IN | Hospital |
| Ascension St Vincent Hospital | Indianapolis, IN | Hospital |
| St Vincent Heart Center | Indianapolis, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St Vincent Medical Group Inc | 7012047640 | 625 |
News Archive
This post in the Ministerial Leadership Initiative's (MLI) "Leading Global Health" blog is "the first of a series of perspective pieces on country ownership from the 'Advancing Country Ownership for Greater Results' roundtable organized last week by" MLI.
Precision medicine - in which diagnosis and treatments are keyed to the genetic susceptibilities of individual cancers - has advanced to the point where it can now impact the care of a majority of children with brain tumors, a new study by investigators at Dana-Farber/Boston Children's Cancer and Blood Disorders Center suggests.
An international study headed by researchers from Aarhus University has for the first time uncovered the large-scale brain patterns and networks which control sleep, providing knowledge which in the future may help the large proportion of people who experience problems sleeping.
U.S. scientists say a detailed analysis of the dog genome answers such questions as how dogs of a different breed still belong to the same species, and may also explain some aspects of human health and biology.
InNexus Biotechnology Inc., a drug development company commercializing the next generation of antibodies based on its groundbreaking Dynamic Cross Linking (DXL™) technology, today announced the Company has entered into a Collaboration Agreement with the National Cancer Institute (NCI) of the U.S. National Institutes of Health (NIH) to research proprietary technologies developed by InNexus.
› Verified 3 days ago
| Entity Name | New Castle Clinic Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346448768 PECOS PAC ID: 3274528757 Enrollment ID: O20070816000444 |
News Archive
This post in the Ministerial Leadership Initiative's (MLI) "Leading Global Health" blog is "the first of a series of perspective pieces on country ownership from the 'Advancing Country Ownership for Greater Results' roundtable organized last week by" MLI.
Precision medicine - in which diagnosis and treatments are keyed to the genetic susceptibilities of individual cancers - has advanced to the point where it can now impact the care of a majority of children with brain tumors, a new study by investigators at Dana-Farber/Boston Children's Cancer and Blood Disorders Center suggests.
An international study headed by researchers from Aarhus University has for the first time uncovered the large-scale brain patterns and networks which control sleep, providing knowledge which in the future may help the large proportion of people who experience problems sleeping.
U.S. scientists say a detailed analysis of the dog genome answers such questions as how dogs of a different breed still belong to the same species, and may also explain some aspects of human health and biology.
InNexus Biotechnology Inc., a drug development company commercializing the next generation of antibodies based on its groundbreaking Dynamic Cross Linking (DXL™) technology, today announced the Company has entered into a Collaboration Agreement with the National Cancer Institute (NCI) of the U.S. National Institutes of Health (NIH) to research proprietary technologies developed by InNexus.
› Verified 3 days ago
| Entity Name | St Vincent Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144513375 PECOS PAC ID: 7012047640 Enrollment ID: O20100609000045 |
News Archive
This post in the Ministerial Leadership Initiative's (MLI) "Leading Global Health" blog is "the first of a series of perspective pieces on country ownership from the 'Advancing Country Ownership for Greater Results' roundtable organized last week by" MLI.
Precision medicine - in which diagnosis and treatments are keyed to the genetic susceptibilities of individual cancers - has advanced to the point where it can now impact the care of a majority of children with brain tumors, a new study by investigators at Dana-Farber/Boston Children's Cancer and Blood Disorders Center suggests.
An international study headed by researchers from Aarhus University has for the first time uncovered the large-scale brain patterns and networks which control sleep, providing knowledge which in the future may help the large proportion of people who experience problems sleeping.
U.S. scientists say a detailed analysis of the dog genome answers such questions as how dogs of a different breed still belong to the same species, and may also explain some aspects of human health and biology.
InNexus Biotechnology Inc., a drug development company commercializing the next generation of antibodies based on its groundbreaking Dynamic Cross Linking (DXL™) technology, today announced the Company has entered into a Collaboration Agreement with the National Cancer Institute (NCI) of the U.S. National Institutes of Health (NIH) to research proprietary technologies developed by InNexus.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Chad Michael Feldman, MD 141 W 22nd St Ste 109, Anderson, IN 46016-4315 Ph: () - | Chad Michael Feldman, MD 141 W 22nd St Ste 109, Anderson, IN 46016-4315 Ph: (765) 646-8538 |
News Archive
This post in the Ministerial Leadership Initiative's (MLI) "Leading Global Health" blog is "the first of a series of perspective pieces on country ownership from the 'Advancing Country Ownership for Greater Results' roundtable organized last week by" MLI.
Precision medicine - in which diagnosis and treatments are keyed to the genetic susceptibilities of individual cancers - has advanced to the point where it can now impact the care of a majority of children with brain tumors, a new study by investigators at Dana-Farber/Boston Children's Cancer and Blood Disorders Center suggests.
An international study headed by researchers from Aarhus University has for the first time uncovered the large-scale brain patterns and networks which control sleep, providing knowledge which in the future may help the large proportion of people who experience problems sleeping.
U.S. scientists say a detailed analysis of the dog genome answers such questions as how dogs of a different breed still belong to the same species, and may also explain some aspects of human health and biology.
InNexus Biotechnology Inc., a drug development company commercializing the next generation of antibodies based on its groundbreaking Dynamic Cross Linking (DXL™) technology, today announced the Company has entered into a Collaboration Agreement with the National Cancer Institute (NCI) of the U.S. National Institutes of Health (NIH) to research proprietary technologies developed by InNexus.
› Verified 3 days ago
Mark Randall Jennings, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2015 Jackson St, Anderson, IN 46016 Phone: 765-649-2511 | |
Dr. Dalwinderpal Singh Samra, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 1547 Ohio Ave., Anderson, IN 46016 Phone: 609-694-8566 | |
Ubaidullah Sharief, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2020 Meridian St Ste 100, Anderson, IN 46016 Phone: 765-646-8509 | |
Adam L Greene, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 141 W 22nd St Ste 109, Anderson, IN 46016 Phone: 765-646-8538 | |
Dr. Edgardo Manuel Flores Anticona, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2101 Jackson St Ste 110, Anderson, IN 46016 Phone: 765-643-6012 Fax: 765-646-9054 | |
Kristine M Rea, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 141 W 22nd St Ste 212, Anderson, IN 46016 Phone: 765-648-4138 |